Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here for more information

Sign In to gain access to subscriptions and/or personal tools.
Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Raszka, W. V.
Right arrow Articles by Zawadsky, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Raszka, W. V., JR
Right arrow Articles by Zawadsky, P. M.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ETHAMBUTOL
*RIFABUTIN
*TRIMETHOPRIM/SULFAMETHOXAZOLE
Social Bookmarking
Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Multifocal M. Intracellulare Osteomyelitis in an Immunocompetent Child

William V. Raszka, JR

Department of Pediatrics, William Beaumont Army Medical Center, El Paso, Texas

Thu-Thao Trinh

Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC

Peter M. Zawadsky

Department of Pediatrics, Walter Reed Army Medical Center, Washington, DC

We report the successful treatment of disseminated Mycobacterium intracellulare osteomyelitis, without evidence of other visceral involvement, in a previously healthy, HIV-negative, 2-year-old female using a 23-month regimen of antimicrobial agents that included 18 months of oral therapy with azithromycin, rifabutin, trimethoprimsulfamethoxazole (TMP/SMX), and ethambutol.

Clinical Pediatrics, Vol. 33, No. 10, 611-616 (1994)
DOI: 10.1177/000992289403301007
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
 Int. J. Syst. Evol. Microbiol.Home page
D. Bang, T. Herlin, M. Stegger, A. B. Andersen, P. Torkko, E. Tortoli, and V. O. Thomsen
Mycobacterium arosiense sp. nov., a slowly growing, scotochromogenic species causing osteomyelitis in an immunocompromised child
Int J Syst Evol Microbiol, October 1, 2008; 58(10): 2398 - 2402.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
S. Okada, N. Ishikawa, K. Shirao, H. Kawaguchi, M. Tsumura, Y. Ohno, S. Yasunaga, M. Ohtsubo, Y. Takihara, and M. Kobayashi
The novel IFNGR1 mutation 774del4 produces a truncated form of interferon-{gamma} receptor 1 and has a dominant-negative effect on interferon-{gamma} signal transduction
J. Med. Genet., August 1, 2007; 44(8): 485 - 491.
[Abstract] [Full Text] [PDF]